In summary, our data show an aberrant NK cell population in the PB and BM from patients with AML in comparison to HDs characterized by increased frequencies of TIGIT+, PVRIG+, CD39+, and CD69+ NK cells. The gene discussed is CD69; the disease is acute myeloid leukemia.